Core Viewpoint - China Tongru (01763) experienced a significant stock increase of over 10%, reaching HKD 20.94 with a trading volume of HKD 24.42 million, following the launch of its carbon isotope product and the second phase of its stable isotope base project in Tongcheng, Anhui on October 31 [1] Group 1: Project Launch and Production Capacity - The newly launched project is expected to produce 2,000 kilograms of high-abundance 13CO gas and 4,000 kilograms of 13C urea raw materials annually, along with other raw materials for gastrointestinal disease treatment drugs [1] - The high-abundance 13CO gas is a critical raw material used in the urea breath test for detecting Helicobacter pylori infections [1] Group 2: Market Impact and Self-Sufficiency - The launch of high-abundance 13CO gas and urea products signifies China's break from long-term reliance on imports for the 13CO gas used in urea breath diagnostics [1] - This development allows China to achieve a fully self-controlled industrial chain in the medical stable isotope carbon sector, from key raw materials to end products, thereby establishing a solid foundation for a safe and reliable high-end medical isotope supply chain [1]
中国同辐午后涨超10% 公司发布碳同位素产品 实现全产业链自主可控